Classification criteria of scleroderma;Critères de classification des sclérodermies

Presse Medicale

Volumn 35, Issue 12 C2, 2006, Pages 1916-1922

  Cabane, Jean ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HUMAN; NOMENCLATURE; PROGNOSIS; QUALITY OF LIFE; RAYNAUD PHENOMENON; REVIEW; SCLERODERMA; SKIN; SYSTEMIC SCLEROSIS;

EID: 33845494072     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(06)74925-9     Document Type: Review

References (16)

1. Torres JE, Sanchez JL. Histopathologic differentiation between localized and systemic scleroderma. Am J Dermatopathol. 1998 Jun; 20: 242-5.
2. Peterson LS, Nelson AM, Su WP. Classification of morphea (localized scleroderma). Mayo Clin Proc. 1995; 70: 1068-76.
3. Zulian F, Athreya BH, Laxer R, Nelson AM, Feitosa de Oliveira SK et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology. 2005.
4. Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J et al., and the Juvenile Scleroderma Working Group of the Pediatric Rheumatology European Society (Pres). Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum. 2005; 52: 2873-81.
5. Barnett AJ, Coventry DA. Scleroderma. Clinical features, course of illness and response to treatment in 61 cases. Med J Aust. 1969; 1: 992-1001.
6. Barnett A, Miller MH, Littlejohn GO. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol. 1988; 15: 276-83.
7. Barnett AJ, Miller M, Littlejohn GO. The diagnosis and classification of scleroderma (systemic sclerosis). Postgrad Med J. 1988; 64: 121-5.
8. Subcommittee for scleroderma criteria of the american rheumatism association diagnostic and therapeutic criteria committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980; 23: 581-90.
9. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA et al. Scleroderma (systemic sclerosis). Classification, subsets, and pathogenesis. J Rheumatol. 1988; 15: 202-5.
10. LeRoy EC, Medsger T. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001; 28: 1573-6.
11. Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR et al. Predicting mortality in systemic sclerosis. Analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine. 2002; 81: 154-67.
12. Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine. 2002; 81: 139-53.
13. Fabien N, Rousset H. Diagnostic immunologique des sclérodermies. Pathol Biol. 2002; 50: 243-55.
14. Pope J. Scleroderma overlap syndromes. Curr Opin Rheumatol. 2002; 14: 704-10.
15. Gelber AC, Wigley FM. Disease severity as a predictor of outcome in scleroderma. Lancet. 2002; 359; 277-9.
16. Wigley FM. When is scleroderma really scleroderma? J Rheumatol. 2001; 28: 1471-3.